Scribble

NTRA Stock Quote Price and Forecast | CNN

NTRA

Natera, Inc.

Key terms

Natera, Inc. is a diagnostics company, which engages in the discovery, development, and commercialization of genetic testing services. It provides Panorama non-invasive prenatal test (NIPT), Vistara, horizon carrier screening (HCS), spectrum pre-implantation genetic screening and spectrum pre-implantation genetic diagnosis, Anora products of conception (POC) and non-invasive paternity testing (PAT). The company was founded by Matthew Rabinowitz and Jonathan Sheena in November 2003 and is headquartered in Austin, TX.

Sector

Industry

Employees

Founded

Website

Key stock statistics

1-day range

52-week range

Market cap

P/E ratio

Next earnings date

Dividend yield

Ex-dividend date

Dividend pay date

Key terms

Smart score

Nov 18 7:23am ET Natera price target raised to $200 from $150 at Piper Sandler by TipRanks Nov 14 2:36am ET Puneet Souda’s Buy Rating Highlights Natera’s Strong Market Position and Growth Potential by TipRanks Nov 13 1:20pm ET Natera price target raised to $176 from $132 at Morgan Stanley by TipRanks Nov 13 9:05am ET Craig-Hallum Remains a Buy on Natera (NTRA) by TipRanks Nov 13 8:55am ET Natera price target raised to $157 from $121 at Craig-Hallum by TipRanks Nov 13 8:19am ET Natera (NTRA) Receives a Buy from Piper Sandler by TipRanks Nov 13 7:37am ET Natera price target raised to $185 from $150 at BTIG by TipRanks Nov 13 7:18am ET Natera price target raised to $175 from $155 at TD Cowen by TipRanks Nov 13 7:03am ET Natera price target raised to $160 from $135 at JPMorgan by TipRanks Nov 13 6:55am ET Natera price target raised to $160 from $120 at Baird by TipRanks Nov 13 4:45am ET Natera price target raised to $165 from $150 at Canaccord by TipRanks Nov 13 12:05am ET Natera’s Strong Financial Performance and Growth Potential Justify Buy Rating by TipRanks Nov 12 11:16pm ET Natera Reports Strong Revenue Growth in Q3 2024 by TipRanks Nov 12 7:40pm ET Closing Bell Movers: Instacart down 6% after earnings by TipRanks Nov 12 4:42pm ET Natera reports Q3 EPS (26c), consensus (57c) by TipRanks Nov 12 4:41pm ET Natera raises FY24 revenue view to $1.61B-$1.64B from $1.49B-$1.52B by TipRanks Nov 12 4:40pm ET Natera jumps 9% to $146.94 after Q3 results, raised FY24 guidance by TipRanks Nov 12 1:10pm ET Notable companies reporting after market close by TipRanks Oct 30 6:36am ET Natera price target raised to $135 from $125 at Bernstein by TipRanks Oct 29 7:01am ET Natera price target raised to $150 from $145 at Canaccord by TipRanks Oct 17 7:36am ET Natera price target raised to $150 from $140 at Leerink by TipRanks Oct 10 8:37am ET Craig-Hallum says buy CareDx as Natera drops pursuit of infringement claims by TipRanks Sep 23 4:11pm ET Natera says court orders injunction against NeoGenomics’ accused RaDaR assay by TipRanks Sep 16 7:10am ET Natera price target raised to $150 from $135 at BTIG by TipRanks Sep 16 5:56am ET Bullish on Natera: Buy Rating Justified by Promising ctDNA Data and Implications for CRC Management by TipRanks Sep 16 5:55am ET Natera’s Signatera MRD Test: A Buy Rating with Anticipated Impact on Clinical Guidelines and Patient Outcomes by TipRanks Sep 15 9:05am ET Natera announces new data from GALAXY arm of ongoing CIRCULATE-Japan trial by TipRanks Sep 13 6:48am ET Piper Sandler Keeps Their Buy Rating on Natera (NTRA) by TipRanks Sep 11 2:08am ET Strong Buy Rating for Natera’s MRD Testing Backed by Promising Clinical Data and Potential for Improved Survival Outcomes by TipRanks Sep 10 7:16am ET TD Cowen Reaffirms Their Buy Rating on Natera (NTRA) by TipRanks Sep 09 12:10pm ET Natera ALTAIR data readout could drive guideline inclusion, says Canaccord by TipRanks

Nov 12 6:30pm ET Natera (NTRA) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates by Zacks Nov 12 5:55pm ET Natera (NTRA) Reports Q3 Loss, Tops Revenue Estimates by Zacks Nov 07 8:41am ET HealthEquity (HQY) Moves 9.8% Higher: Will This Strength Last? by Zacks Nov 07 8:25am ET Viatris (VTRS) Beats Q3 Earnings and Revenue Estimates by Zacks Nov 06 6:30pm ET Enhabit (EHAB) Misses Q3 Earnings and Revenue Estimates by Zacks Oct 30 6:20am ET Is SPDR S&P Biotech ETF (XBI) a Strong ETF Right Now? by Zacks Oct 23 12:00pm ET All You Need to Know About Natera (NTRA) Rating Upgrade to Strong Buy by Zacks Oct 23 10:15am ET Best Momentum Stocks to Buy for October 23rd by Zacks

1-year income & revenue

Key terms

analyst rating

buy
hold
sell

1-year stock price forecast

$ Market cap P/E ratio $ Price 1d change 52-week range

Key terms

Latest investing news

Target expects a sluggish holiday season.

David Paul Morris/Bloomberg/Getty Images

Target sounds the alarm bell on holiday shopping

Investors piled into safe havens like gold and US debt as tensions rose in Europe. Gold prices jumped on Tuesday and US Treasury rates dipped.

Angela Weiss/AFP/Getty Images

Stocks shrug off concerns about heightened US-Russia tensions

A lone shopper places items in her cart in the frozen food aisle of a Walmart store Thursday, Nov. 14, 2024, in Englewood, Colo.

David Zalubowski/AP

As Americans bargain shop, six-figure earners flock to Walmart

NEW YORK, NEW YORK - JULY 07: Bikes with Grubhub bags sit on the street on July 07, 2023 in New York City. Grubhub, DoorDash and Uber Eats sued the City of New York on July 6th in order to block its new minimum pay rules for food delivery workers. (Photo by Leonardo Munoz/VIEWpress)

Leonardo Munoz/VIEWpress/Getty Images

Grubhub just sold for $650 million. Four years ago it was worth $7.3 billion